Research Blog

NSE Backtesting Articles

Guides, strategy research, and methodology explainers for Indian equity investors who want to build and test data-driven strategies.

What is Backtesting? A Beginner's Guide for Indian Stock Market Investors
Learn what backtesting means, why it matters for Indian equity investors, and how to run your first backtest on NSE stocks using historical price and fundamental data.
Read article
NIFTY50 vs NIFTY100 vs NIFTY200 — Which Universe Should You Backtest?
Understand the difference between NIFTY50, NIFTY100, and NIFTY200 as backtesting universes for Indian equity strategies — liquidity, diversification, and survivorship bias explained.
Read article
Understanding Sharpe Ratio and Drawdown in Indian Equity Strategies
A practical guide to reading Sharpe ratio, Sortino ratio, and maximum drawdown in backtest results for NSE equity strategies — what the numbers actually tell you.
Read article
Momentum vs Mean-Reversion: Which Strategy Works on NSE?
Compare momentum and mean-reversion strategies on Indian NSE stocks — historical backtest patterns, typical holding periods, and which market conditions favour each approach.
Read article
How to Avoid Survivorship Bias When Backtesting Indian Stocks
Survivorship bias silently inflates backtest returns. Learn what it is, how it affects NSE backtests, and how ftInvstr controls for it using point-in-time universe membership.
Read article
Lookahead Bias on Indian XBRL Filings — Why Your Fundamental Backtest Is Lying
Most fundamental backtests on Indian stocks treat quarterly results as if they were available on the period-end date. They were not. The filing arrived 30-60 days later. Anchoring data to the period end instead of the filing date silently inflates backtest returns by 1.5-3.5% CAGR. Here's why, by how much, and how to fix it.
Read article
Factor Investing in India — A Live Tour of 20 Backtested Strategies (2020–2026)
Factor investing on Indian equities, anchored in 20 live backtested strategies on NSE — Momentum, Quality, Quality × Momentum, Profitability, Flow factors. Real CAGR, Sharpe, max drawdown, Monte Carlo distribution. Point-in-time XBRL data, survivorship-controlled.
Read article